Thrombocytopenia (Low Platelets)
Evaluation of bleeding risk associated with low platelet counts.
This content is for general information; please consult your physician for diagnosis and treatment.
This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →
What is Thrombocytopenia (Low Platelets)?
Thrombocytopenia is defined as a platelet count below 150,000/microliter (the lower limit of normal). Platelets are essential blood cells that form the initial plug at sites of vascular injury and trigger the coagulation cascade. When their numbers drop, the body's ability to stop bleeding is impaired, and severity correlates roughly with platelet count.
Thrombocytopenia results from one or more of three mechanisms: decreased production (bone marrow failure, chemotherapy, viral infection, vitamin deficiency), increased destruction (immune thrombocytopenia, ITP; thrombotic thrombocytopenic purpura, TTP; disseminated intravascular coagulation, DIC), or sequestration in an enlarged spleen (cirrhosis, portal hypertension).
Bleeding risk varies with platelet count: above 50,000/μL surgical bleeding is usually controlled; below 20,000/μL spontaneous bleeding can occur; below 10,000/μL the risk of intracranial or major hemorrhage rises significantly. Workup focuses on identifying the underlying cause through blood smear examination, bone marrow biopsy if needed, and targeted serologic and imaging studies.
Symptoms
Risk Factors
When to See a Doctor?
If you experience any of the following symptoms, seek medical attention promptly:
- Unexplained bruising or petechiae appearance
- Bleeding from gums, nose, or other sites without injury
- Heavy menstrual bleeding requiring frequent pad changes
- Severe headache with platelet count under 20,000/μL
- Pre-procedural evaluation if known low platelets
- After starting new medication and developing bruising
- During or after viral illness with persistent bruising
- Family history of bleeding or platelet disorders for screening
Treatment Methods
Which Department to Visit?
You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.
Learn About Hematoloji DepartmentLet us help you
You can make an appointment with our specialists or contact us for your concerns.
Related Health Topics
Other articles from the same department you may want to explore.
Anaemia
Dahiliye (İç Hastalıkları)
Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.
Iron Deficiency Anaemia
Dahiliye (İç Hastalıkları)
Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.
Vitamin B12 Deficiency
Dahiliye (İç Hastalıkları)
Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.
Hypertension (High Blood Pressure) Management
Dahiliye (İç Hastalıkları)
Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.
Chronic Kidney Disease
Dahiliye (İç Hastalıkları)
Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.
Hepatitis B (HBV)
Dahiliye (İç Hastalıkları)
Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.
Hepatitis C (HCV)
Dahiliye (İç Hastalıkları)
Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.
Fatty Liver Disease
Dahiliye (İç Hastalıkları)
Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.
Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.